Hepcludex (bulevirtide)
pCPA File Number:
23353
Negotiation Status:
Under consideration for negotiation
Indication(s):
Chronic hepatitis delta virus (HDV) infection
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
SR0881-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable